Guardant Health to Participate in Upcoming Investor Conferences

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the following investor conferences.

• William Blair 44^th Annual Growth Stock Conference in Chicago
  Presentation on Tuesday, June 4 at 3:20 p.m. CT / 4:20 p.m. ET

• Jefferies Global Healthcare Conference in New York
  Presentation on Wednesday, June 5 at 5:00 p.m. ET / 2:00 p.m. PT

• Goldman Sachs 45^th Annual Global Healthcare Conference in Miami Beach, Florida
  Fireside chat on Tuesday, June 11 at 2:00 p.m. ET / 11:00 a.m. PT

Interested parties may access live and archived webcasts of the sessions on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health

Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240522599294/en/

The Guardant Health Stock at the time of publication of the news with a fall of -4,56 % to 20,73EUR on Lang & Schwarz stock exchange (22. Mai 2024, 22:08 Uhr).